Lack of synergism between dazoxiben and dipyridamole following administration to man

This publication has 18 references indexed in Scilit:

• Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2
  Biochemical Pharmacology, 1984
• Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatrom
  Biochemical Pharmacology, 1983
• Effect of thromboxane synthetase inhibitors on platelet function: Enhancement by inhibition of phosphodiesterase
  Thrombosis Research, 1982
• Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production
  Biochemical Pharmacology, 1982
• THROMBOXANE SYNTHETASE INHIBITION AS ANTITHROMBOTIC STRATEGY
  The Lancet, 1981
• INHIBITION OF THROMBOXANE SYNTHETASE DOES NOT NECESSARILY PREVENT PLATELET AGGREGATION
  The Lancet, 1981
• The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets
  Thrombosis Research, 1981
• Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour
  Thrombosis Research, 1980
• DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN
  The Lancet, 1978
• Calcium-dependent stimulation of platelet aggregation by PGE2
  Nature, 1975